|
Assessment of participants’ on admission to study
| | | |
|
Assessment of prevention method under review
| | | |
|
Participants were stratified for the cervical cancer prevention or screening method under review
| | | |
|
Ascertainment of cervical cancer and HIV status, prospectively from participants through diagnosis, laboratory tests and blood tests
| | | |
|
Ascertainment of cervical cancer and HIV status, retrospectively from participants through diagnosis, laboratory tests and blood tests
| | | |
|
Complete follow-up—all subjects accounted for
| | | |
|
Subjects lost to follow up unlikely to introduce bias (≥75% follow-up or description provided of those lost
| | | |
|
If groups were not stratified for prevention and screening methods and the distribution was unbalanced, were outcomes adjusted for
| | | |
